Today's Clinical Lab - News, Editorial and Products for the Clinical Laboratory
Lab technician holding blood vial marked HIV negative
iStock, Thomas Faull

COVID-19 Disruptions in HIV Testing, Prevention Highlight Need for Innovation

The rapid rebound in services, if scaled up, could help reach national prevention goals

Centers for Disease Control and Prevention

CDC is one of the major operating components of the Department of Health and Human Services.

ViewFull Profile
Learn about ourEditorial Policies.
Published:Dec 02, 2022
|2 min read
Register for free to listen to this article
Listen with Speechify

The nation’s ability to prevent HIV was dealt a hard blow early in the COVID-19 pandemic, according to a new CDC analysis published on World AIDS Day: Putting Ourselves to the Test: Achieving Equity to End HIV

HIV testing and prescriptions for pre-exposure prophylaxis (PrEP) dropped substantially during the onset of the COVID-19 pandemic in 2020. HIV tests declined about 32 percent between the first and second quarters of the year, and PrEP prescriptions fell about 6 percent. Testing and PrEP prescriptions started to rebound in the second half of 2020, but they did not reach pre-pandemic levels until early 2021. The initial falloffs were likely due to disruptions to in-person clinic services and redeployment of public health staff to respond to COVID-19.

Although HIV testing and PrEP prescriptions were disrupted with the arrival of the COVID-19 pandemic, the provision of highly effective HIV treatment remained strong. The proportion of people linked to care after they received an HIV diagnosis—and the proportion of people with HIV with a suppressed viral load—both remained stable.

To overcome serious roadblocks and maintain access to critical HIV services, communities, clinicians, and health care systems launched or expanded an array of programs that included telehealth, self-testing, and home-delivery of HIV treatment. A number of efforts by the Health Resources and Services Administration and Ryan White HIV/AIDS program prevented treatment interruptions.

Investment in local community innovation is vital to strengthening our nation’s HIV prevention and care systems to endure future public health emergencies. Expanding those innovations can also help achieve national goals to end the HIV epidemic.

Jonathan Mermin, MD, MPH, Director of CDC’s National Center for HIV, Viral Hepatitis, STD, and TB Prevention, says: “Today, the world celebrates the dedication, resilience, and creativity of people with HIV and their public health and clinical allies who refused to let a new pandemic stand in the way of ending a longstanding one. It is just this type of resolve that, when paired with resources, will enable the nation to weather public health emergencies and prevent HIV at the same time.”

- This press release was originally published on the Centers for Disease Control and Prevention website